UNIGE document Scientific Article
previous document  unige:32495  next document
add to browser collection
Title

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration

Authors
Chatzidionysiou, Katerina
Lie, Elisabeth
Nasonov, Evgeny
Lukina, Galina
Hetland, Merete Lund
Tarp, Ulrik
van Riel, Piet L C M
Nordström, Dan C
show hidden authors show all authors [1 - 14]
Published in Annals of the Rheumatic Diseases. 2012, vol. 71, no. 3, p. 374-7
Abstract To compare the effectiveness and safety of rituximab alone or in combination with either methotrexate or leflunomide.
Keywords AdultAgedAntibodies, Monoclonal, Murine-Derived/adverse effects/therapeutic useAntirheumatic Agents/adverse effects/therapeutic useArthritis, Rheumatoid/drug therapyDrug Therapy, CombinationEpidemiologic MethodsFemaleHumansImmunosuppressive Agents/adverse effects/therapeutic useIsoxazoles/administration & dosage/adverse effectsMaleMethotrexate/administration & dosage/adverse effectsMiddle AgedProduct Surveillance, Postmarketing/methodsTreatment Outcome
Identifiers
PMID: 21972242
Full text
Article (Published version) (137 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
CHATZIDIONYSIOU, Katerina et al. Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration. In: Annals of the Rheumatic Diseases, 2012, vol. 71, n° 3, p. 374-7. https://archive-ouverte.unige.ch/unige:32495

183 hits

0 download

Update

Deposited on : 2013-12-18

Export document
Format :
Citation style :